Differential expression of Huntington's disease gene (IT15) mRNA in developing rat brain.
暂无分享,去创建一个
[1] Elena Cattaneo,et al. Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.
[2] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.
[3] S. Augood,et al. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellularin situ hybridization study , 1996, Neuroscience.
[4] R. Roos,et al. Characterization and localization of the Huntington disease gene product. , 1993, Human molecular genetics.
[5] Joseph B. Martin,et al. Somatostatin is increased in the basal ganglia in Huntington disease , 1983, Annals of neurology.
[6] D. Surmeier,et al. Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington’s Disease , 1999, The Journal of Neuroscience.
[7] Ben A. Oostra,et al. Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.
[8] G. Bernhard Landwehrmeyer,et al. IT15 gene expression in fetal human brain , 1994, Brain Research.
[9] R. Durbin,et al. Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat , 1994, Somatic cell and molecular genetics.
[10] M. MacDonald,et al. Mutant Huntingtin Forms in Vivo Complexes with Distinct Context-Dependent Conformations of the Polyglutamine Segment , 1999, Neurobiology of Disease.
[11] P. Willems. Dynamic mutations hit double figures , 1994, Nature Genetics.
[12] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[13] A. Young,et al. A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.
[14] G. Bernardi,et al. Huntingtin distribution among striatal output neurons of normal rat brain , 2003, Neuroscience Letters.
[15] P. Emson,et al. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease , 1985, Brain Research.
[16] S. Folstein. Huntington's disease : a disorder of families , 1989 .
[17] Huda Y. Zoghbi,et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.
[18] J. Penney,et al. Homozygotes for Huntington's disease , 1987, Nature.
[19] L. Farrer,et al. Homozygote for Huntington disease. , 1989, American journal of human genetics.
[20] R. Gibbs,et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. , 1993, Science.
[21] C A Ross,et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.
[22] R. Albin,et al. Genetics and molecular biology of Huntington's disease , 1995, Trends in Neurosciences.
[23] J. Sutcliffe,et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.
[24] M. McInnis,et al. Genes with triplet repeats: candidate mediators of neuropsychiatric disorders , 1993, Trends in Neurosciences.
[25] S. Floresco,et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.
[26] J. Penney,et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis , 1995, Neuroscience.
[27] O. Riess,et al. Expression of the Huntington disease gene in rodents: cloning the rat homologue and evidence for downregulation in non-neuronal tissues during development. , 1995, Human molecular genetics.
[28] Edwin Reyniers,et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.
[29] J. Sutcliffe,et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.
[30] S. Folstein,et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.
[31] R. Carraway,et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.
[32] Y. Agid,et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.
[33] Christopher A Ross,et al. Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.
[34] J. Penney,et al. Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.
[35] D. Housman,et al. Molecular approaches to hereditary diseases of the nervous system: Huntington's disease as a paradigm. , 1991, Annual review of neuroscience.
[36] C. L. Warner,et al. Meiotic stability and genotype – phenotype correlation of the trinucleotide repeat in X–linked spinal and bulbar muscular atrophy , 1992, Nature Genetics.
[37] R. Richards,et al. Heritable unstable DNA sequences , 1992, Nature Genetics.
[38] Peter S. Harper,et al. Huntington's disease , 1991 .
[39] G. Bernardi,et al. Co‐localization of brain‐derived neurotrophic factor (BDNF) and wild‐type huntingtin in normal and quinolinic acid‐lesioned rat brain , 2003, The European journal of neuroscience.
[40] Paul W Goldberg,et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. , 1994, The New England journal of medicine.
[41] C. Ross,et al. Expression of the Huntington's disease (IT15) protein product in HD patients. , 1995, Human molecular genetics.
[42] P G Bhide,et al. Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.
[43] U. Kumar,et al. Expression of NMDA Receptor-1 (NR1) and Huntingtin in Striatal Neurons Which Colocalize Somatostatin, Neuropeptide Y, and NADPH Diaphorase: A Double-Label Histochemical and Immunohistochemical Study , 1997, Experimental Neurology.
[44] M. MacDonald,et al. Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum , 1997, The Journal of Neuroscience.
[45] J. Penney,et al. Huntingtin localization in brains of normal and Huntington's disease patients , 1997, Annals of neurology.
[46] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[47] Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade. , 1995 .
[48] K. Fischbeck,et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.
[49] M. MacDonald,et al. Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals , 1995, Annals of neurology.
[50] J. Rommens,et al. Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. , 1993, Human molecular genetics.
[51] L. Surh,et al. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene , 1993, Nature Genetics.
[52] Blair R. Leavitt,et al. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.
[53] R. Albin,et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.